Unity Biotechnology President Nathaniel David's 2018 pay rises 12% to $2.9M

Unity Biotechnology reports 2018 executive compensation

By ExecPay News

Published: April 24, 2020

Unity Biotechnology reported fiscal year 2018 executive compensation information on April 24, 2020.
In 2018, four executives at Unity Biotechnology received on average a compensation package of $1.9M, a 44% decrease compared to previous year.
Average pay of disclosed executives at Unity Biotechnology
Nathaniel E. David, President, received $2.9M in total, which increased by 12% compared to 2017.
Keith R. Leonard Jr, Chief Executive Officer, received a compensation package of $2.7M, which decreased by 32% compared to previous year. 67% of the compensation package, or $1.8M, was in option awards.
Jamie Dananberg, Chief Medical Officer, earned $952K in 2018.
Robert C. Goeltz II, Chief Financial Officer, received $908K in 2018.

Related executives

Robert Goeltz

Unity Biotechnology

Chief Financial Officer

Keith Leonard

Unity Biotechnology

Chief Executive Officer

Nathaniel David

Unity Biotechnology

President

Jamie Dananberg

Unity Biotechnology

Chief Medical Officer

You may also like

Source: SEC filing on April 24, 2020.